Fortify Ventures

Fortify invests in technology that measurably improves human performance — helping people feel better, function better, and perform better. The firm targets early-stage companies building consumer-centric products anchored in real-world behavior, with a preference for hardware-enabled experiences where software amplifies the physical product. It explicitly avoids biotech, pharma, medical devices, and enterprise clinical workflow tools.

Fortify is comfortable leading rounds but does not require it. The firm prioritizes the quality of the company and its ability to be an effective partner. It targets a 7% ownership stake with its initial check and will only invest when there is enough capital committed to act as a clear catalyst for growth, avoiding rolling rounds that lack a defined milestone.

Fortify's mandate is exclusively focused on human health and performance technology. It will only invest in products used by people that drive real improvements in health or performance, whether that is direct-to-consumer, B2B benefiting employees, or a marketplace. Enterprise infrastructure, clinical workflow tools, biotech, pharma, and medical devices are all explicitly outside the firm's investment scope.

Both current and prospective limited partners can reach out to Fortify directly at IR@fortify.vc. The firm maintains a dedicated LP relations function and commits to having the appropriate team member respond.